APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Skincare

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Peptide Skincare Market Outlook and Growth Opportunities 2026

22 December 2025211 pages

Choose your research edition.

Industry ResearchPeptide Skincare Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Skincare Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Peptide Skincare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Skincare Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Skincare Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Peptide Skincare market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Peptide Skincare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peptide Skincare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Skincare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Peptide Skincare market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Peptide Skincare market include L’Oréal, Estée Lauder, Unilever, Procter & Gamble, Avon Products (Natura &Co), Shiseido, Colgate-Palmolive, Geoskincare (nzskincare) and Revision Skincare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Peptide Skincare market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peptide Skincare and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peptide Skincare sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Peptide Skincare market size, projected growth trends, production technologies, key applications, and end-use industries.

Peptide Skincare Segment by Company

L’Oréal

Estée Lauder

Unilever

Procter & Gamble

Avon Products (Natura &Co)

Shiseido

Colgate-Palmolive

Geoskincare (nzskincare)

Revision Skincare

Peter Thomas Roth

Jan Marini Skin Research

Eminence Organic Skin Care

BrandMD Skincare

Vivier Pharma

Prima-Derm

Sisley

StriVectin (Crown Laboratories)

Elizabeth Arden (Revlon)

SkinMedica (Allergan)

NeoStrata (Johnson & Johnson)

Alastin Skincare

Elemis (L'Occitane)

Peptide Skincare Segment by Type

Serums

Moisturizers

Face Cream

Eyes Cream

Others

Peptide Skincare Segment by Sale Channels

Supermarket

Specialty Retailers

Online

Others

Peptide Skincare Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Peptide Skincare status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Peptide Skincare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Peptide Skincare significant trends, drivers, influence factors in global and regions.

6. To analyze Peptide Skincare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Skincare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Skincare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Skincare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Peptide Skincare market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide Skincare industry.

Chapter 3: Detailed analysis of Peptide Skincare manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Peptide Skincare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Peptide Skincare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Peptide Skincare Industry Trends Table 2. Peptide Skincare Industry Drivers Table 3. Peptide Skincare Industry Opportunities and Challenges Table 4. Peptide Skincare Industry Restraints Table 5. Global Peptide Skincare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Peptide Skincare Revenue Share by Company (2021-2026) Table 7. Global Peptide Skincare Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Peptide Skincare Sales Volume Share by Company (2021-2026) Table 9. Global Peptide Skincare Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Peptide Skincare Company Ranking, (2024-2026) & (USD Million) Table 11. Global Peptide Skincare Key Company Manufacturing Base & Headquarters Table 12. Global Peptide Skincare Company, Product Type & Application Table 13. Global Peptide Skincare Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Peptide Skincare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Serums Table 18. Significant Companies of Moisturizers Table 19. Significant Companies of Face Cream Table 20. Significant Companies of Eyes Cream Table 21. Significant Companies of Others Table 22. Global Peptide Skincare Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Peptide Skincare Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Peptide Skincare Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Peptide Skincare Sales Volume Share by Type (2021-2026) Table 26. Global Peptide Skincare Sales Volume Share by Type (2027-2032) Table 27. Global Peptide Skincare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Peptide Skincare Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Peptide Skincare Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Peptide Skincare Sales Value Share by Type (2021-2026) Table 31. Global Peptide Skincare Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Supermarket Table 33. Significant Companies of Specialty Retailers Table 34. Significant Companies of Online Table 35. Significant Companies of Others Table 36. Global Peptide Skincare Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Peptide Skincare Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Peptide Skincare Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Peptide Skincare Sales Volume Share by Application (2021-2026) Table 40. Global Peptide Skincare Sales Volume Share by Application (2027-2032) Table 41. Global Peptide Skincare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Peptide Skincare Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Peptide Skincare Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Peptide Skincare Sales Value Share by Application (2021-2026) Table 45. Global Peptide Skincare Sales Value Share by Application (2027-2032) Table 46. Global Peptide Skincare Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Peptide Skincare Sales by Region (2021-2026) & (K Units) Table 48. Global Peptide Skincare Sales Market Share by Region (2021-2026) Table 49. Global Peptide Skincare Sales by Region (2027-2032) & (K Units) Table 50. Global Peptide Skincare Sales Market Share by Region (2027-2032) Table 51. Global Peptide Skincare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Peptide Skincare Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Peptide Skincare Sales Value Share by Region (2021-2026) Table 54. Global Peptide Skincare Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Peptide Skincare Sales Value Share by Region (2027-2032) Table 56. Global Peptide Skincare Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Peptide Skincare Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Peptide Skincare Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Peptide Skincare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Peptide Skincare Sales by Country (2021-2026) & (K Units) Table 61. Global Peptide Skincare Sales Market Share by Country (2021-2026) Table 62. Global Peptide Skincare Sales by Country (2027-2032) & (K Units) Table 63. Global Peptide Skincare Sales Market Share by Country (2027-2032) Table 64. Global Peptide Skincare Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Peptide Skincare Sales Value Market Share by Country (2021-2026) Table 66. Global Peptide Skincare Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Peptide Skincare Sales Value Market Share by Country (2027-2032) Table 68. L’Oréal Company Information Table 69. L’Oréal Business Overview Table 70. L’Oréal Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. L’Oréal Peptide Skincare Product Portfolio Table 72. L’Oréal Recent Development Table 73. Estée Lauder Company Information Table 74. Estée Lauder Business Overview Table 75. Estée Lauder Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Estée Lauder Peptide Skincare Product Portfolio Table 77. Estée Lauder Recent Development Table 78. Unilever Company Information Table 79. Unilever Business Overview Table 80. Unilever Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Unilever Peptide Skincare Product Portfolio Table 82. Unilever Recent Development Table 83. Procter & Gamble Company Information Table 84. Procter & Gamble Business Overview Table 85. Procter & Gamble Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Procter & Gamble Peptide Skincare Product Portfolio Table 87. Procter & Gamble Recent Development Table 88. Avon Products (Natura &Co) Company Information Table 89. Avon Products (Natura &Co) Business Overview Table 90. Avon Products (Natura &Co) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Avon Products (Natura &Co) Peptide Skincare Product Portfolio Table 92. Avon Products (Natura &Co) Recent Development Table 93. Shiseido Company Information Table 94. Shiseido Business Overview Table 95. Shiseido Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Shiseido Peptide Skincare Product Portfolio Table 97. Shiseido Recent Development Table 98. Colgate-Palmolive Company Information Table 99. Colgate-Palmolive Business Overview Table 100. Colgate-Palmolive Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Colgate-Palmolive Peptide Skincare Product Portfolio Table 102. Colgate-Palmolive Recent Development Table 103. Geoskincare (nzskincare) Company Information Table 104. Geoskincare (nzskincare) Business Overview Table 105. Geoskincare (nzskincare) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Geoskincare (nzskincare) Peptide Skincare Product Portfolio Table 107. Geoskincare (nzskincare) Recent Development Table 108. Revision Skincare Company Information Table 109. Revision Skincare Business Overview Table 110. Revision Skincare Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Revision Skincare Peptide Skincare Product Portfolio Table 112. Revision Skincare Recent Development Table 113. Peter Thomas Roth Company Information Table 114. Peter Thomas Roth Business Overview Table 115. Peter Thomas Roth Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Peter Thomas Roth Peptide Skincare Product Portfolio Table 117. Peter Thomas Roth Recent Development Table 118. Jan Marini Skin Research Company Information Table 119. Jan Marini Skin Research Business Overview Table 120. Jan Marini Skin Research Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Jan Marini Skin Research Peptide Skincare Product Portfolio Table 122. Jan Marini Skin Research Recent Development Table 123. Eminence Organic Skin Care Company Information Table 124. Eminence Organic Skin Care Business Overview Table 125. Eminence Organic Skin Care Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Eminence Organic Skin Care Peptide Skincare Product Portfolio Table 127. Eminence Organic Skin Care Recent Development Table 128. BrandMD Skincare Company Information Table 129. BrandMD Skincare Business Overview Table 130. BrandMD Skincare Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. BrandMD Skincare Peptide Skincare Product Portfolio Table 132. BrandMD Skincare Recent Development Table 133. Vivier Pharma Company Information Table 134. Vivier Pharma Business Overview Table 135. Vivier Pharma Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Vivier Pharma Peptide Skincare Product Portfolio Table 137. Vivier Pharma Recent Development Table 138. Prima-Derm Company Information Table 139. Prima-Derm Business Overview Table 140. Prima-Derm Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Prima-Derm Peptide Skincare Product Portfolio Table 142. Prima-Derm Recent Development Table 143. Sisley Company Information Table 144. Sisley Business Overview Table 145. Sisley Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Sisley Peptide Skincare Product Portfolio Table 147. Sisley Recent Development Table 148. StriVectin (Crown Laboratories) Company Information Table 149. StriVectin (Crown Laboratories) Business Overview Table 150. StriVectin (Crown Laboratories) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. StriVectin (Crown Laboratories) Peptide Skincare Product Portfolio Table 152. StriVectin (Crown Laboratories) Recent Development Table 153. Elizabeth Arden (Revlon) Company Information Table 154. Elizabeth Arden (Revlon) Business Overview Table 155. Elizabeth Arden (Revlon) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Elizabeth Arden (Revlon) Peptide Skincare Product Portfolio Table 157. Elizabeth Arden (Revlon) Recent Development Table 158. SkinMedica (Allergan) Company Information Table 159. SkinMedica (Allergan) Business Overview Table 160. SkinMedica (Allergan) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. SkinMedica (Allergan) Peptide Skincare Product Portfolio Table 162. SkinMedica (Allergan) Recent Development Table 163. NeoStrata (Johnson & Johnson) Company Information Table 164. NeoStrata (Johnson & Johnson) Business Overview Table 165. NeoStrata (Johnson & Johnson) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. NeoStrata (Johnson & Johnson) Peptide Skincare Product Portfolio Table 167. NeoStrata (Johnson & Johnson) Recent Development Table 168. Alastin Skincare Company Information Table 169. Alastin Skincare Business Overview Table 170. Alastin Skincare Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Alastin Skincare Peptide Skincare Product Portfolio Table 172. Alastin Skincare Recent Development Table 173. Elemis (L'Occitane) Company Information Table 174. Elemis (L'Occitane) Business Overview Table 175. Elemis (L'Occitane) Peptide Skincare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. Elemis (L'Occitane) Peptide Skincare Product Portfolio Table 177. Elemis (L'Occitane) Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Peptide Skincare Distributors List Table 181. Peptide Skincare Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Peptide Skincare Product Image Figure 2. Global Peptide Skincare Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptide Skincare Sales Value (2021-2032) & (US$ Million) Figure 4. Global Peptide Skincare Sales (2021-2032) & (K Units) Figure 5. Global Peptide Skincare Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Peptide Skincare Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Serums Image Figure 10. Moisturizers Image Figure 11. Face Cream Image Figure 12. Eyes Cream Image Figure 13. Others Image Figure 14. Global Peptide Skincare Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Peptide Skincare Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Peptide Skincare Sales Volume Share by Type (2021-2032) Figure 17. Global Peptide Skincare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Peptide Skincare Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Peptide Skincare Sales Value Share by Type (2021-2032) Figure 20. Supermarket Image Figure 21. Specialty Retailers Image Figure 22. Online Image Figure 23. Others Image Figure 24. Global Peptide Skincare Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Peptide Skincare Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Peptide Skincare Sales Volume Share by Application (2021-2032) Figure 27. Global Peptide Skincare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Peptide Skincare Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Peptide Skincare Sales Value Share by Application (2021-2032) Figure 30. Global Peptide Skincare Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Peptide Skincare Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Peptide Skincare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Peptide Skincare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Peptide Skincare Sales Value (2021-2032) & (US$ Million) Figure 35. North America Peptide Skincare Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Peptide Skincare Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Peptide Skincare Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Peptide Skincare Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Peptide Skincare Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Peptide Skincare Sales Value (2021-2032) & (US$ Million) Figure 41. South America Peptide Skincare Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Peptide Skincare Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Peptide Skincare Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Peptide Skincare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Peptide Skincare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Peptide Skincare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Peptide Skincare Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Peptide Skincare Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Serums
  • Moisturizers
  • Face Cream
  • Eyes Cream
  • Others
Applications
  • Supermarket
  • Specialty Retailers
  • Online
  • Others
Companies covered
  • L’Oréal
  • Estée Lauder
  • Unilever
  • Procter & Gamble
  • Avon Products (Natura &Co)
  • Shiseido
  • Colgate-Palmolive
  • Geoskincare (nzskincare)
  • Revision Skincare
  • Peter Thomas Roth
  • Jan Marini Skin Research
  • Eminence Organic Skin Care
  • BrandMD Skincare
  • Vivier Pharma
  • Prima-Derm
  • Sisley
  • StriVectin (Crown Laboratories)
  • Elizabeth Arden (Revlon)
  • SkinMedica (Allergan)
  • NeoStrata (Johnson & Johnson)
  • Alastin Skincare
  • Elemis (L'Occitane)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peptide Skincare Sales Value (2021-2032)
  4. 1.2.2 Global Peptide Skincare Sales Volume (2021-2032)
  5. 1.2.3 Global Peptide Skincare Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Peptide Skincare Market Dynamics
  1. 2.1 Peptide Skincare Industry Trends
  2. 2.2 Peptide Skincare Industry Drivers
  3. 2.3 Peptide Skincare Industry Opportunities and Challenges
  4. 2.4 Peptide Skincare Industry Restraints
3 Peptide Skincare Market by Company
  1. 3.1 Global Peptide Skincare Company Revenue Ranking in 2025
  2. 3.2 Global Peptide Skincare Revenue by Company (2021-2026)
  3. 3.3 Global Peptide Skincare Sales Volume by Company (2021-2026)
  4. 3.4 Global Peptide Skincare Average Price by Company (2021-2026)
  5. 3.5 Global Peptide Skincare Company Ranking (2024-2026)
  6. 3.6 Global Peptide Skincare Company Manufacturing Base and Headquarters
  7. 3.7 Global Peptide Skincare Company Product Type and Application
  8. 3.8 Global Peptide Skincare Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Peptide Skincare Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Peptide Skincare Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Peptide Skincare Market by Type
  1. 4.1 Peptide Skincare Type Introduction
  2. 4.1.1 Serums
  3. 4.1.2 Moisturizers
  4. 4.1.3 Face Cream
  5. 4.1.4 Eyes Cream
  6. 4.1.5 Others
  7. 4.2 Global Peptide Skincare Sales Volume by Type
  8. 4.2.1 Global Peptide Skincare Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Peptide Skincare Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Peptide Skincare Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Peptide Skincare Sales Value by Type
  12. 4.3.1 Global Peptide Skincare Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Peptide Skincare Sales Value by Type (2021-2032)
  14. 4.3.3 Global Peptide Skincare Sales Value Share by Type (2021-2032)
5 Peptide Skincare Market by Application
  1. 5.1 Peptide Skincare Application Introduction
  2. 5.1.1 Supermarket
  3. 5.1.2 Specialty Retailers
  4. 5.1.3 Online
  5. 5.1.4 Others
  6. 5.2 Global Peptide Skincare Sales Volume by Application
  7. 5.2.1 Global Peptide Skincare Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Peptide Skincare Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Peptide Skincare Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Peptide Skincare Sales Value by Application
  11. 5.3.1 Global Peptide Skincare Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Peptide Skincare Sales Value by Application (2021-2032)
  13. 5.3.3 Global Peptide Skincare Sales Value Share by Application (2021-2032)
6 Peptide Skincare Regional Sales and Value Analysis
  1. 6.1 Global Peptide Skincare Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peptide Skincare Sales by Region (2021-2032)
  3. 6.2.1 Global Peptide Skincare Sales by Region: 2021-2026
  4. 6.2.2 Global Peptide Skincare Sales by Region (2027-2032)
  5. 6.3 Global Peptide Skincare Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Peptide Skincare Sales Value by Region (2021-2032)
  7. 6.4.1 Global Peptide Skincare Sales Value by Region: 2021-2026
  8. 6.4.2 Global Peptide Skincare Sales Value by Region (2027-2032)
  9. 6.5 Global Peptide Skincare Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Peptide Skincare Sales Value (2021-2032)
  12. 6.6.2 North America Peptide Skincare Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Peptide Skincare Sales Value (2021-2032)
  15. 6.7.2 Europe Peptide Skincare Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Peptide Skincare Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Peptide Skincare Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Peptide Skincare Sales Value (2021-2032)
  21. 6.9.2 South America Peptide Skincare Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Peptide Skincare Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Peptide Skincare Sales Value Share by Country, 2025 VS 2032
7 Peptide Skincare Country-level Sales and Value Analysis
  1. 7.1 Global Peptide Skincare Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Peptide Skincare Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Peptide Skincare Sales by Country (2021-2032)
  4. 7.3.1 Global Peptide Skincare Sales by Country (2021-2026)
  5. 7.3.2 Global Peptide Skincare Sales by Country (2027-2032)
  6. 7.4 Global Peptide Skincare Sales Value by Country (2021-2032)
  7. 7.4.1 Global Peptide Skincare Sales Value by Country (2021-2026)
  8. 7.4.2 Global Peptide Skincare Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Peptide Skincare Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Peptide Skincare Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Peptide Skincare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Peptide Skincare Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Peptide Skincare Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Peptide Skincare Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Peptide Skincare Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Peptide Skincare Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Peptide Skincare Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Peptide Skincare Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Peptide Skincare Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Peptide Skincare Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Peptide Skincare Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Peptide Skincare Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Peptide Skincare Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Peptide Skincare Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Peptide Skincare Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Peptide Skincare Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Peptide Skincare Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Peptide Skincare Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Peptide Skincare Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Peptide Skincare Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Peptide Skincare Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Peptide Skincare Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Peptide Skincare Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Peptide Skincare Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Peptide Skincare Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Peptide Skincare Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Peptide Skincare Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Peptide Skincare Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Peptide Skincare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 L’Oréal
  2. 8.1.1 L’Oréal Company Information
  3. 8.1.2 L’Oréal Business Overview
  4. 8.1.3 L’Oréal Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 L’Oréal Peptide Skincare Product Portfolio
  6. 8.1.5 L’Oréal Recent Developments
  7. 8.2 Estée Lauder
  8. 8.2.1 Estée Lauder Company Information
  9. 8.2.2 Estée Lauder Business Overview
  10. 8.2.3 Estée Lauder Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Estée Lauder Peptide Skincare Product Portfolio
  12. 8.2.5 Estée Lauder Recent Developments
  13. 8.3 Unilever
  14. 8.3.1 Unilever Company Information
  15. 8.3.2 Unilever Business Overview
  16. 8.3.3 Unilever Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Unilever Peptide Skincare Product Portfolio
  18. 8.3.5 Unilever Recent Developments
  19. 8.4 Procter & Gamble
  20. 8.4.1 Procter & Gamble Company Information
  21. 8.4.2 Procter & Gamble Business Overview
  22. 8.4.3 Procter & Gamble Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Procter & Gamble Peptide Skincare Product Portfolio
  24. 8.4.5 Procter & Gamble Recent Developments
  25. 8.5 Avon Products (Natura &Co)
  26. 8.5.1 Avon Products (Natura &Co) Company Information
  27. 8.5.2 Avon Products (Natura &Co) Business Overview
  28. 8.5.3 Avon Products (Natura &Co) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Avon Products (Natura &Co) Peptide Skincare Product Portfolio
  30. 8.5.5 Avon Products (Natura &Co) Recent Developments
  31. 8.6 Shiseido
  32. 8.6.1 Shiseido Company Information
  33. 8.6.2 Shiseido Business Overview
  34. 8.6.3 Shiseido Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shiseido Peptide Skincare Product Portfolio
  36. 8.6.5 Shiseido Recent Developments
  37. 8.7 Colgate-Palmolive
  38. 8.7.1 Colgate-Palmolive Company Information
  39. 8.7.2 Colgate-Palmolive Business Overview
  40. 8.7.3 Colgate-Palmolive Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Colgate-Palmolive Peptide Skincare Product Portfolio
  42. 8.7.5 Colgate-Palmolive Recent Developments
  43. 8.8 Geoskincare (nzskincare)
  44. 8.8.1 Geoskincare (nzskincare) Company Information
  45. 8.8.2 Geoskincare (nzskincare) Business Overview
  46. 8.8.3 Geoskincare (nzskincare) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Geoskincare (nzskincare) Peptide Skincare Product Portfolio
  48. 8.8.5 Geoskincare (nzskincare) Recent Developments
  49. 8.9 Revision Skincare
  50. 8.9.1 Revision Skincare Company Information
  51. 8.9.2 Revision Skincare Business Overview
  52. 8.9.3 Revision Skincare Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Revision Skincare Peptide Skincare Product Portfolio
  54. 8.9.5 Revision Skincare Recent Developments
  55. 8.10 Peter Thomas Roth
  56. 8.10.1 Peter Thomas Roth Company Information
  57. 8.10.2 Peter Thomas Roth Business Overview
  58. 8.10.3 Peter Thomas Roth Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Peter Thomas Roth Peptide Skincare Product Portfolio
  60. 8.10.5 Peter Thomas Roth Recent Developments
  61. 8.11 Jan Marini Skin Research
  62. 8.11.1 Jan Marini Skin Research Company Information
  63. 8.11.2 Jan Marini Skin Research Business Overview
  64. 8.11.3 Jan Marini Skin Research Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jan Marini Skin Research Peptide Skincare Product Portfolio
  66. 8.11.5 Jan Marini Skin Research Recent Developments
  67. 8.12 Eminence Organic Skin Care
  68. 8.12.1 Eminence Organic Skin Care Company Information
  69. 8.12.2 Eminence Organic Skin Care Business Overview
  70. 8.12.3 Eminence Organic Skin Care Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Eminence Organic Skin Care Peptide Skincare Product Portfolio
  72. 8.12.5 Eminence Organic Skin Care Recent Developments
  73. 8.13 BrandMD Skincare
  74. 8.13.1 BrandMD Skincare Company Information
  75. 8.13.2 BrandMD Skincare Business Overview
  76. 8.13.3 BrandMD Skincare Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 BrandMD Skincare Peptide Skincare Product Portfolio
  78. 8.13.5 BrandMD Skincare Recent Developments
  79. 8.14 Vivier Pharma
  80. 8.14.1 Vivier Pharma Company Information
  81. 8.14.2 Vivier Pharma Business Overview
  82. 8.14.3 Vivier Pharma Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Vivier Pharma Peptide Skincare Product Portfolio
  84. 8.14.5 Vivier Pharma Recent Developments
  85. 8.15 Prima-Derm
  86. 8.15.1 Prima-Derm Company Information
  87. 8.15.2 Prima-Derm Business Overview
  88. 8.15.3 Prima-Derm Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Prima-Derm Peptide Skincare Product Portfolio
  90. 8.15.5 Prima-Derm Recent Developments
  91. 8.16 Sisley
  92. 8.16.1 Sisley Company Information
  93. 8.16.2 Sisley Business Overview
  94. 8.16.3 Sisley Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sisley Peptide Skincare Product Portfolio
  96. 8.16.5 Sisley Recent Developments
  97. 8.17 StriVectin (Crown Laboratories)
  98. 8.17.1 StriVectin (Crown Laboratories) Company Information
  99. 8.17.2 StriVectin (Crown Laboratories) Business Overview
  100. 8.17.3 StriVectin (Crown Laboratories) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 StriVectin (Crown Laboratories) Peptide Skincare Product Portfolio
  102. 8.17.5 StriVectin (Crown Laboratories) Recent Developments
  103. 8.18 Elizabeth Arden (Revlon)
  104. 8.18.1 Elizabeth Arden (Revlon) Company Information
  105. 8.18.2 Elizabeth Arden (Revlon) Business Overview
  106. 8.18.3 Elizabeth Arden (Revlon) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Elizabeth Arden (Revlon) Peptide Skincare Product Portfolio
  108. 8.18.5 Elizabeth Arden (Revlon) Recent Developments
  109. 8.19 SkinMedica (Allergan)
  110. 8.19.1 SkinMedica (Allergan) Company Information
  111. 8.19.2 SkinMedica (Allergan) Business Overview
  112. 8.19.3 SkinMedica (Allergan) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 SkinMedica (Allergan) Peptide Skincare Product Portfolio
  114. 8.19.5 SkinMedica (Allergan) Recent Developments
  115. 8.20 NeoStrata (Johnson & Johnson)
  116. 8.20.1 NeoStrata (Johnson & Johnson) Company Information
  117. 8.20.2 NeoStrata (Johnson & Johnson) Business Overview
  118. 8.20.3 NeoStrata (Johnson & Johnson) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 NeoStrata (Johnson & Johnson) Peptide Skincare Product Portfolio
  120. 8.20.5 NeoStrata (Johnson & Johnson) Recent Developments
  121. 8.21 Alastin Skincare
  122. 8.21.1 Alastin Skincare Company Information
  123. 8.21.2 Alastin Skincare Business Overview
  124. 8.21.3 Alastin Skincare Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Alastin Skincare Peptide Skincare Product Portfolio
  126. 8.21.5 Alastin Skincare Recent Developments
  127. 8.22 Elemis (L'Occitane)
  128. 8.22.1 Elemis (L'Occitane) Company Information
  129. 8.22.2 Elemis (L'Occitane) Business Overview
  130. 8.22.3 Elemis (L'Occitane) Peptide Skincare Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Elemis (L'Occitane) Peptide Skincare Product Portfolio
  132. 8.22.5 Elemis (L'Occitane) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Peptide Skincare Value Chain Analysis
  2. 9.1.1 Peptide Skincare Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Peptide Skincare Sales Mode & Process
  6. 9.2 Peptide Skincare Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Peptide Skincare Distributors
  9. 9.2.3 Peptide Skincare Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst